The 9th Annual Future of the Pharmaceutical Benefits Scheme Summit

The 9^th Annual
Future of the Pharmaceutical Benefits Scheme Summit
12th and 13th April 2012 | Sydney Harbour Marriott

The increasing concern over the sustainability of the Pharmaceutical Benefits Scheme (PBS) is putting this key pillar of Australia’s healthcare system into the spotlight of scrutiny.

The Future of the PBS Summit, back for its 9^th year, will address the major issues relating to the sustainability of the scheme. Calling on key industry stakeholders and experts, this summit will tackle the difficult questions relating to controversial PBS government reform and the impact that this will have on pharmaceutical companies, consumers, the government and the future of medical research in Australia.

Confirmed speakers so far include:

• Dr. Paul Gross, Director, Institute of Health Economics and Technology Assessment (IHETA)
• Kos Sclavos, President, Pharmacy Guild of Australia
• Warwick Plunkett, Immediate Past President, Pharmaceutical Society of Australia
• Dr Brendan Shaw, Chief Executive, Medicines Australia
• Kate Lynch, CEO, Generic Medicines industry Association (GMiA)
• Elizabeth Foley, Chief Executive Officer, Research Australia
• Lynne Pezzullo, Director, Lead Partner, Health Economics and Social Policy, Deloitte Access Economics
• Rollo Manning, Pharmacy and Public Relations Consultant, RWM Consultancy, Darwin NT

Key topics include:

• US free trade: The Trans Pacific Partnership Agreement
• PBS deferrals
• The universality of the PBS
• Establishing a PharmaCare Agency
• Paying the right price for Pharmaceuticals
• The case for PBS Reform and the effect of reform to date
• PBS reform and the impact on consumers
• Panel Discussion: Conflicts of interest and pharma marketing

For speaking opportunities, contact Madeline Vaughan on: (+61 2) 9080 4036 or E-mail: madeline.vaughan@informa.com.au

For sponsorship opportunities, contact Samuel Wilson on: (+61 2) 9080 4371 or E-Mail: samuel.wilson@informa.com.au